Voluntary Recall Information

Philips Respironics Sleep and Respiratory Care devices


In June 2021, after discovering a potential health risk related to the foam in certain CPAP, BiPAP and Mechanical Ventilator devices, Philips Respironics issued a voluntary Field Safety Notice (outside U.S.) / voluntary recall notification (U.S. only).


We are focused on delivering the best care possible, while supporting patients, customers and clinicians throughout the remediation process.

An update on our progress 


Globally, we have remediated 99% of actionable* sleep therapy device registrations to date. 

As the remediation of the ventilator devices continues, Philips Respironics will be communicating with Durable Medical Equipment providers (DMEs) directly throughout the process. If you are a patient or caregiver with an affected Philips Respironics ventilation device, you do not need to take any action. All ventilation remediation will be handled via your DME.

*Actionable registrations are those that contain the necessary information needed to complete the remediation and are not awaiting further information.

Stop icon

Ozone and UV light cleaning products are not currently approved cleaning methods for sleep apnea devices or masks and should not be used.

Latest updates

Explained: The voluntary Philips Respironics sleep and respiratory care devices recall*


* This is a voluntary recall notification in the US and field safety notice in other countries

Explained: The Philips Respironics Consent Decree

April 4, 2024

Resolution of Philips Respironics litigation


For more information on the medical monitoring settlement, please visit RespironicsMedicalAdvancementProgram.com.  

Resolution of US economic loss litigation reached


Philips has reached an agreement, subject to final Court approval, to resolve all economic loss claims brought by private plaintiffs in the United States related to the Philips Respironics voluntary recall of certain sleep and respiratory care devices.

All related inquiries should be directed to the third-party Settlement Administrator, Angeion Group. For more information, please visit www.RespironicsCPAP-ELSettlement.com or call 855-912-3432.

You are about to visit a Philips global content page


You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.